Cargando…

Protein methyltransferase inhibitors as precision cancer therapeutics: a decade of discovery

The protein methyltransferases (PMTs) represent a large class of enzymes that catalyse the methylation of side chain nitrogen atoms of the amino acids lysine or arginine at specific locations along the primary sequence of target proteins. These enzymes play a key role in the spatio-temporal control...

Descripción completa

Detalles Bibliográficos
Autor principal:	Copeland, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915721/ https://www.ncbi.nlm.nih.gov/pubmed/29685962 http://dx.doi.org/10.1098/rstb.2017.0080

Ejemplares similares

Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics
por: Copeland, R A, et al.
Publicado: (2013)

Discovery of a potent and dual-selective bisubstrate inhibitor for protein arginine methyltransferase 4/5
por: Al-Hamashi, Ayad A., et al.
Publicado: (2021)

Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors
por: Lin, Hong, et al.
Publicado: (2019)

Discovery of Cofactor Competitive Inhibitors against the Human Methyltransferase Fibrillarin
por: Shi, Yun, et al.
Publicado: (2021)

Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3)
por: Kaniskan, H. Ümit, et al.
Publicado: (2017)

Selective Inhibitors of Protein Methyltransferases
por: Kaniskan, H. Ümit, et al.
Publicado: (2014)

Inhibitors of Protein Methyltransferases and Demethylases
por: Kaniskan, H. Ümit, et al.
Publicado: (2017)

Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8
por: Ma, Anqi, et al.
Publicado: (2014)

Therapeutic potential of DNA methyltransferase inhibitors with immune checkpoint inhibitor therapy in breast cancer
por: Luo, Na, et al.
Publicado: (2018)

Identification of a peptide inhibitor for the histone methyltransferase WHSC1
por: Morrison, Michael J., et al.
Publicado: (2018)

DNA methylation in cancer: three decades of discovery
por: Feinberg, Andrew
Publicado: (2014)

Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
por: Qi, Ya-Nan, et al.
Publicado: (2023)

Discovery of a Non-Nucleoside SETD2 Methyltransferase Inhibitor against Acute Myeloid Leukemia
por: Bajusz, Dávid, et al.
Publicado: (2021)

Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies
por: Lampe, John W., et al.
Publicado: (2021)

Molecular Modeling of Inhibitors of Human DNA Methyltransferase with a Crystal Structure: Discovery of a Novel DNMT1 Inhibitor
por: Yoo, Jakyung, et al.
Publicado: (2012)

Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase
por: Silhan, Jan, et al.
Publicado: (2023)

A Pan-Inhibitor for Protein Arginine Methyltransferase Family Enzymes
por: Iyamu, Iredia D., et al.
Publicado: (2021)

Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity
por: Rogawski, David S., et al.
Publicado: (2021)

A decade of immune-checkpoint inhibitors in cancer therapy
por: Robert, Caroline
Publicado: (2020)

Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies
por: Sauter, Camille, et al.
Publicado: (2022)

Discovery and characterization of naturally occurring potent inhibitors of catechol-O-methyltransferase from herbal medicines
por: Zhao, Dong-Fang, et al.
Publicado: (2021)

Clinical proteomics: a driving force for cancer therapeutic target discovery and precision medicine
por: Wang, Hao, et al.
Publicado: (2019)

Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor
por: Feoli, Alessandra, et al.
Publicado: (2023)

Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases
por: Kanwal, Rajnee, et al.
Publicado: (2016)

Comparative Study of Adenosine Analogs as Inhibitors of Protein Arginine Methyltransferases and a Clostridioides difficile-Specific DNA Adenine Methyltransferase
por: Zhou, Jujun, et al.
Publicado: (2023)

Protein Arginine Methyltransferase 5 as a Therapeutic Target for KRAS Mutated Colorectal Cancer
por: Shifteh, David, et al.
Publicado: (2020)

A decade of Genome Medicine: toward precision medicine
por: Begum, Rabia
Publicado: (2019)

Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma
por: Nguyen, Hong Phuong, et al.
Publicado: (2023)

Synthesis of lysine methyltransferase inhibitors
por: Hui, Chunngai, et al.
Publicado: (2015)

Correction: Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases
por: Kanwal, Rajnee, et al.
Publicado: (2016)

Neurokinin B and pre-eclampsia: a decade of discovery
por: Page, Nigel M
Publicado: (2010)

Retrospective on a decade of machine learning for chemical discovery
por: von Lilienfeld, O. Anatole, et al.
Publicado: (2020)

GATA2 deficiency syndrome: A decade of discovery
por: Homan, Claire C., et al.
Publicado: (2021)

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
por: Vinet, Mathilde, et al.
Publicado: (2019)

Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
por: Bobrovs, Raitis, et al.
Publicado: (2021)

New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
por: Jain, Tejeshwar, et al.
Publicado: (2021)

Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction–Reconstruction and Fragment-Growing Approach
por: Iannelli, Giulia, et al.
Publicado: (2022)

CARM1 arginine methyltransferase as a therapeutic target for cancer
por: Santos, Margarida, et al.
Publicado: (2023)

Selective small-chemical inhibitors of protein arginine methyltransferase 5 with anti-lung cancer activity
por: Kong, Gui-Mei, et al.
Publicado: (2017)

Corrigendum: Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma
por: Nguyen, Hong Phuong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r7qqhp77934netpo6n8t18o4nh